Chief Excecutive Officer of IAG and mathematician with 10+ years expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Chair of IAG’s Scientifc Advisory Board and ex-head of R&D for Lilly, with 20+ years of R&D global pharmaceutical companies, developing treatments in immunology, neurology and oncology.

IAG’s CTO and expert in medical image analysis, data mining, algorithm development, medical image and video processing, mathematical, stochastic and forecasting modelling and numerical analysis.

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

IAG’s COO and Industry’s Veteran with 20+ years of experience growing teams and scaling operations to delivery programs for Bio-Pharma industry.

IAG’s CFO and Investment Professional with 20+ years of Expertise in Life science Industry

Jeremy has served as a Global Client Adviser for Healthcare in Oracle for 10 years.

Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.

Expert in transforming the process of medical innovation in response to the future challenges facing healthcare worldwide, and advising and assisting life science enterprises.

Expert in clinical research with a special focus on implementing risk-based monitoring and cost-benefit optimization.